Background: The purpose of this work was to describe the experiences of EMS personnel in responding to drug overdose-related calls and the impact the pandemic has had to help better inform current response and treatment efforts.

Methods: Semi-structured interviews were conducted with 99 EMS personnel across 18 areas throughout the United States that were designated as Early Warning Network sentinel sites by the National Institute on Drug Abuse-funded National Drug Early Warning System. Participants were asked about topics including the potential burdens from the pandemic and the opioid crisis. We coded the interview responses and identified themes through qualitative analysis. Multiple cycles of descriptive coding, recoding, subcoding, pattern-coding, and thematic coding of responses were conducted.

Results: Responses were categorized into the following themes: 1) being over-worked from increased call volume; 2) increased risk for personal harm when responding to patients; 3) compassion fatigue due to long hours and repeat calls for the same people; 4) conflicting perceptions of the utility of naloxone; 5) the need for better treatment options to respond to opioid crisis on top of COVID-19.

Conclusions: The burden of the substance use disorder (SUD) crisis on EMS personnel has been compounded by the COVID-19 pandemic. These reports from EMS personnel throughout the US can help inform policy and procedures to better protect the mental health of EMS personnel and to ensure better care for patients with SUD. These experiences and recommendations may be of use for other countries as substance use and COVID-19 are global health issues.

Keywords: Emergency medical services, Substance use, Opioids, Overdose, COVID-19, Prehospital care


[1] Alexander K, Pogorzelska-Maziarz M, Gerolamo A, Hassen N, Kelly EL, Rising KL. The impact of COVID-19 on healthcare delivery for people who use opioids: a scoping review. Subst Abuse Treat Prev Pol 2021;16(1):60. https://doi.org/10.1186/s13011-021-00395-6.

[2] Bennett AS, Elliott L. Naloxone's role in the national opioid crisis-past struggles, current efforts, and future opportunities. Transl Res 2021;234:43-57. https://doi.org/10.1016/j.trsl.2021.03.001.

[3] Bird SM, McAuley A, Perry S, Hunter C. Effectiveness of Scotland's National Naloxone Programme for reducing opioid-related deaths: a before (2006-10) versus after (2011-13) comparison. Addiction 2016;111(5):883-91. https://doi.org/10.1111/add.13265.

[4] Blanco C, Compton WM, Volkow ND. Opportunities for research on the treatment of substance use disorders in the context of COVID-19. JAMA Psychiatr 2021;78(4):357-8. https://doi.org/10.1001/jamapsychiatry.2020.3177.

[5] Blue H, Dahly A, Chhen S, Lee J, Shadiow A, Van Deelen AG, et al. Rural emergency medical service providers perceptions on the causes of and solutions to the opioid crisis: a qualitative assessment. J Prim Care Commun Health 2021;12:2150132720987715. https://doi.org/10.1177/2150132720987715.

[6] Brooks SK, Webster RK, Smith LE, Woodland L, Wessely S, Greenberg N, et al. The psychological impact of quarantine and how to reduce it: rapid review of the evidence. Lancet 2020;395(10227):912-20. https://doi.org/10.1016/s0140-6736(20)30460-8.

[7] Cantor J, McBain RK, Kofner A, Hanson R, Stein BD, Yu H. Telehealth adoption by mental health and substance use disorder treatment facilities in the COVID-19 pandemic. Psychiatr Serv 2022;73(4):411-7. https://doi.org/10.1176/appi.ps.202100191.

[8] Cash RE, Kinsman J, Crowe RP, Rivard MK, Faul M, Panchal AR. Naloxone administration frequency during emergency medical service events - United States, 2012-2016. MMWR Morb Mortal Wkly Rep 2018;67(31):850-3. https://doi.org/10.15585/mmwr.mm6731a2.

[9] Centers for Disease Control and Prevention [CDC]. Drug Overdose Deaths in the U.S. Top 100,000 Annually. 2022 Jan 25. Available from: https://www.cdc.gov/nchs/pressroom/nchs_press_releases/2021/20211117.htm.

[10] Centers for Disease Control and Prevention [CDC]. Products Vital Statistics Rapid Release - Provisional Drug Overdose Data. 2022 Feb 9. Available from: https://www.cdc.gov/nchs/nvss/vsrr/drug-overdose-data.htm.

[11] Champagne-Langabeer T, Bakos-Block C, Yatsco A, Langabeer JR. Emergency medical services targeting opioid user disorder: an exploration of current out-of-hospital post overdose interventions. J Am Coll Emerg Phys Open 2020;1(6):1230-9. https://doi.org/10.1002/emp2.12208.

[12] Chandran K, Mazer-Amirshahi M, Shankar N, Desale S, Nelson L, Mete M. Impact of COVID-19 pandemic on emergency department substance use screens and overdose presentations. Am J Emerg Med 2021;50:472-6. https://doi.org/10.1016/j.ajem.2021.08.058.

[13] Coffin PO, Sullivan SD. Cost-effectiveness of distributing naloxone to heroin users for lay overdose reversal. Ann Intern Med 2013;158(1):1-9. https://doi.org/10.7326/0003-4819-158-1-201301010-00003.

[14] Cottler LB, Goldberger BA, Nixon SJ, Striley CW, Barenholtz E, Fitzgerald ND, et al. Introducing NIDA's New national drug early warning system. Drug Alcohol Depend 2020;217:108286. https://doi.org/10.1016/j.drugalcdep.2020.108286.

[15] Crowe RP, Fernandez AR, Pepe PE, Cash RE, Rivard MK, Wronski R, et al. The association of job demands and resources with burnout among emergency medical services professionals. J Am Coll Emerg Phys Open 2020;1(1):6-16. https://doi.org/10.1002/emp2.12014.

[16] Ducar DM, Penberthy JK, Schorling JB, Leavell VA, Calland JF. Mindfulness for healthcare providers fosters professional quality of life and mindful attention among emergency medical technicians. Explore 2020;16(1):61-8. https://doi.org/10.1016/j.explore.2019.07.015.

[17] Enteen L, Bauer J, McLean R, Wheeler E, Huriaux E, Kral AH, et al. Overdose prevention and naloxone prescription for opioid users in San Francisco. J Urban Health 2010;87(6):931-41. https://doi.org/10.1007/s11524-010-9495-8.

[18] Friedman J, Beletsky L, Schriger DL. Overdose-related cardiac arrests observed by emergency medical services during the US COVID-19 epidemic. JAMA Psychiatr 2021;78(5):562-4. https://doi.org/10.1001/jamapsychiatry.2020.4218.

[19] Glenn MJ, Rice AD, Primeau K, Hollen A, Jado I, Hannan P, et al. Refusals after prehospital administration of naloxone during the COVID-19 pandemic. Prehosp Emerg Care 2021;25(1):46-54. https://doi.org/10.1080/10903127.2020.1834656.

[20] Handberry M, Bull-Otterson L, Dai M, Mann NC, Chaney E, Ratto J, et al. Changes in emergency medical services before and during the COVID-19 pandemic in the United States, January 2018-December 2020. Clin Infect Dis 2021;73(Suppl 1):S84-91. https://doi.org/10.1093/cid/ciab373.

[21] Hennink MM, Kaiser BN, Marconi VC. Code saturation versus meaning saturation: how many interviews are enough? Qual Health Res 2017;27(4):591-608. https://doi.org/10.1177/1049732316665344.

[22] Joiner A, Kumar L, Barhorst B. Braithwaite S, for the public health committee on behalf of the NAEMSP board of directors. The role of emergency medical services in the opioid epidemic. Prehosp Emerg Care 2021;25(4):462-4. https://doi.org/10.1080/10903127.2020.1810372.

[23] Kerensky T, Walley AY. Opioid overdose prevention and naloxone rescue kits: what we know and what we don't know. Addiction Sci Clin Pract 2017;12(1):4. https://doi.org/10.1186/s13722-016-0068-3.

[24] Khoury D, Preiss A, Geiger P, Anwar M, Conway KP. Increases in naloxone administrations by emergency medical services providers during the COVID-19 pandemic: retrospective time series study. JMIR Public Health Surveill 2021;7(5):e29298. https://doi.org/10.2196/29298.

[25] Maragh-Bass AC, Fields JC, McWilliams J, Knowlton AR. Challenges and opportunities to engaging emergency medical service providers in substance use research: a qualitative study. Prehospital Disaster Med 2017;32(2):148-55. https://doi.org/10.1017/s1049023x16001424.

[26] Miles MB, Huberman AM, Saldana J. Qualitative data analysis: a methods sourcebook. third ed. Thousand Oaks, CA: SAGE; 2014.

[27] Naumann RB, Durrance CP, Ranapurwala SI, Austin AE, Proescholdbell S, Childs R, et al. Impact of a community based naloxone distribution program on opioid overdose death rates. Drug Alcohol Depend 2019;204:107536. https://doi.org/10.1016/j.drugalcdep.2019.06.038.

[28] Patel I, Walter LA, Li L. Opioid overdose crises during the COVID-19 pandemic: implication of health disparities. Harm Reduct J 2021;18(1):89. https://doi.org/10.1186/s12954-021-00534-z.

[29] R Core Team. R. A language and environment for statistical computing. Vienna, Austria: R Foundation for Statistical Computing; 2019.

[30] Roth K, Baier N, Felgner S, Busse R, Henschke C. Association between safety culture and risk of burnout: a survey of nonmedical rescue workers. Gesundheitswesen 2022;84(3):199-207. https://doi.org/10.1055/a-1276-0817.

[31] Shreffler J, Shreffler M, Murfree JR, Huecker M. A global pandemic and substance use disorder: healthcare professionals' viewpoints on the merging of two crises. Subst Use Misuse 2021;56(10):1476-82. https://doi.org/10.1080/10826084.2021.1936052.

[32] Slavova S, Rock P, Bush HM, Quesinberry D, Walsh SL. Signal of increased opioid overdose during COVID-19 from emergency medical services data. Drug Alcohol Depend 2020;214:108176. https://doi.org/10.1016/j.drugalcdep.2020.108176.

[33]Smyser PA, Lubin JS. Surveying the opinions of Pennsylvania Chiefs of Police toward officers carrying and administering naloxone. Am J Drug Alcohol Abuse 2018;44(2):244-51. https://doi.org/10.1080/00952990.2017.1339053.

[34] Winhusen T, Wilder C, Lyons MS, Theobald J, Kropp F, Lewis D. Evaluation of a personally-tailored opioid overdose prevention education and naloxone distribution intervention to promote harm reduction and treatment readiness in individuals actively using illicit opioids. Drug Alcohol Depend 2020;216:108265. https://doi.org/10.1016/j.drugalcdep.2020.108265.

[35] Volkow ND. Collision of the COVID-19 and addiction epidemics. Ann Intern Med 2020;173(1):61-2. https://doi.org/10.7326/m20-1212.

[36] Mountfort S, Wilson J. EMS provider health and wellness. 2021 Sep 15. Available from: http://www.ncbi.nlm.nih.gov/books/NBK493236/.

[37] Saldana J. The coding manual for qualitative researchers. 2021 Aug 30. Available from: https://www.academia.edu/11310253/The_coding_manual_for_qualitative_researchers.

[38] National Institute on Drug Abuse. Naloxone drug facts. 2022 [cited 2022 Jan 25]. Available from: https://www.drugabuse.gov/publications/drugfacts/naloxone.

[39] National Drug Early Warning System (NDEWS). 2022 Mar 23. Available from: https://ndews.org/.

[40] Friese S. ATLAS.ti 8 Windows - User Manual. 2022 Mar 23. Available from: http://downloads.atlasti.com/docs/manual/atlasti_v8_manual_en.pdf.